A German biotechnology company base...

A German biotechnology company based in Martinsried, GPC Biotech, raised e786 million in June [i]or[/i] part of to the other public and private placements in Germany, the US, and other countries. "Our fresh financing was one of the chiefly successful biotech offerings in limits of proceeds for the year to date, in succession either side of the Atlantic," said Dr Bernd Seizinger, CEO of GPC It is now individual of the few German biotechnology companies listed forward NASDAQ.

More righteous news came from Berlin-based biotech company Epigenomics, which went public onward the Frankfurt stock exchange in July--the first